Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 20|pp. 23810–23830
CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
Back to articleFigure 3(3 of 8)
100%
Figure 3
Figure 3.Comparison of mutation (A) and CNV (B) landscapes between CCR5 high expression and low expression groups.